Caplight Directory>Companies>Aloe Therapeutics-preview>Aloetherapeutics


Aloe Therapeutics

Aloe Therapeutics

Private
Germantown, MarylandHealthcare & Life Scienceshttps://aloetherapeutics.com

Last Round

Pre Seed

Apr 8, 2024

Total Funding Raised

$200,000

Company Overview

Aloe Therapeutics is a biotechnology company developing a locally delivered, cell-based immunotherapy, Allo-Immunotherapy (AIM), to increase the efficacy of treatments for solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Non-AI

Keywords

cell therapyimmunotherapysolid tumor therapy'off-the-shelf' cell therapyallogeneic cell therapy'cold' to 'hot' tumorscheckpoint inhibitor combinationimmuno-oncologytumor microenvironment modulationin situ vaccinelocal immunotherapyclinical-stage biotechdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aloe Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Aloe Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Pre SeedApr 8, 2024
View all Funding Rounds

Key People

Founding team and executive leadership

Martha Sklavos

Founder CEO

Founding Team

Aloe Therapeutics Investors

Notable investors and investment history

InvestorRounds
TEDCOPre Seed
Springboard EnterprisesPre Seed
The Innovation SpacePre Seed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 6, 2025

    Added Fox Rothschild LLP, a legal services firm, as a customer.

  • Jan 2, 2025

    Added BioHealth Innovation, Inc. as a customer.

View all signals

Aloe Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aloe Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aloe Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersGermantown, Maryland
Employee Range1
Year Founded2019
Last FundingApr 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.